Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Pilot Study to Evaluate Atibuclimab (IC14) for Treatment of Acute Decompensated Heart Failure

NCT06556810 is registered in ClinicalTrials.gov with Implicit Bioscience as lead sponsor.

NCT NCT06556810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06556810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Pilot Study to Evaluate Atibuclimab (IC14) for Treatment of Acute Decompensated Heart Failure
Lead sponsor
Implicit Bioscience
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
October 17, 2024
Completion date
August 28, 2026
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure